- call +1-201-465-4211
- email sales@mrinsights.biz
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Scope of the Report:
This report focuses on the Dermatology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Dermatology Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
External Use
Oral
Injection
Market Segment by Applications, can be divided into
Psoriasis
Skin Infections
Acne
Dermatitis
Other
There are 15 Chapters to deeply display the global Dermatology Drugs market.
Chapter 1, to describe Dermatology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dermatology Drugs, with sales, revenue, and price of Dermatology Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatology Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dermatology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dermatology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Dermatology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 External Use
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Applications
1.3.1 Psoriasis
1.3.2 Skin Infections
1.3.3 Acne
1.3.4 Dermatitis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Dermatology Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Dermatology Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Dermatology Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Galderma
2.4.1 Business Overview
2.4.2 Dermatology Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Galderma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Dermatology Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Dermatology Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Dermatology Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merz Pharma
2.8.1 Business Overview
2.8.2 Dermatology Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merz Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Valeant
2.9.1 Business Overview
2.9.2 Dermatology Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Valeant Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 LEO Pharma
2.10.1 Business Overview
2.10.2 Dermatology Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 LEO Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Dermatology Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dermatology Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatology Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatology Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Dermatology Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dermatology Drugs Market Analysis by Regions
4.1 Global Dermatology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatology Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dermatology Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Dermatology Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Dermatology Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatology Drugs Sales and Growth Rate (2013-2018)
4.5 South America Dermatology Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatology Drugs Sales and Growth Rate (2013-2018)
5 North America Dermatology Drugs by Countries
5.1 North America Dermatology Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatology Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dermatology Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Dermatology Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Dermatology Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Dermatology Drugs Sales and Growth Rate (2013-2018)
6 Europe Dermatology Drugs by Countries
6.1 Europe Dermatology Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatology Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dermatology Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dermatology Drugs Sales and Growth Rate (2013-2018)
6.3 UK Dermatology Drugs Sales and Growth Rate (2013-2018)
6.4 France Dermatology Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Dermatology Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Dermatology Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dermatology Drugs by Countries
7.1 Asia-Pacific Dermatology Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatology Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatology Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Dermatology Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Dermatology Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Dermatology Drugs Sales and Growth Rate (2013-2018)
7.5 India Dermatology Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dermatology Drugs Sales and Growth Rate (2013-2018)
8 South America Dermatology Drugs by Countries
8.1 South America Dermatology Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatology Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dermatology Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dermatology Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Dermatology Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Dermatology Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dermatology Drugs by Countries
9.1 Middle East and Africa Dermatology Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatology Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatology Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dermatology Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Dermatology Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Dermatology Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Dermatology Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Dermatology Drugs Sales and Growth Rate (2013-2018)
10 Global Dermatology Drugs Market Segment by Type
10.1 Global Dermatology Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatology Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatology Drugs Revenue and Market Share by Type (2013-2018)
10.2 External Use Sales Growth and Price
10.2.1 Global External Use Sales Growth (2013-2018)
10.2.2 Global External Use Price (2013-2018)
10.3 Oral Sales Growth and Price
10.3.1 Global Oral Sales Growth (2013-2018)
10.3.2 Global Oral Price (2013-2018)
10.4 Injection Sales Growth and Price
10.4.1 Global Injection Sales Growth (2013-2018)
10.4.2 Global Injection Price (2013-2018)
11 Global Dermatology Drugs Market Segment by Application
11.1 Global Dermatology Drugs Sales Market Share by Application (2013-2018)
11.2 Psoriasis Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Acne Sales Growth (2013-2018)
11.5 Dermatitis Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Dermatology Drugs Market Forecast (2018-2023)
12.1 Global Dermatology Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatology Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatology Drugs Market Forecast (2018-2023)
12.2.2 Europe Dermatology Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatology Drugs Market Forecast (2018-2023)
12.2.4 South America Dermatology Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatology Drugs Market Forecast (2018-2023)
12.3 Dermatology Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Dermatology Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatology Drugs Market Share Forecast by Type (2018-2023)
12.4 Dermatology Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Dermatology Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatology Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dermatology Drugs Picture
Table Product Specifications of Dermatology Drugs
Figure Global Sales Market Share of Dermatology Drugs by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
